Today, we are performing a case of cryoablation for a patient with indolent lymphoma in the lungs.
The patient is a 69-year-old individual who, five years ago, was diagnosed with indolent lymphoma in the lungs. Initially, the patient declined surgery. In September 2018, cryoablation was performed, and upon reevaluation on October 24th, one month later, the tumor imaging revealed a necrotic state.
Subsequently, the patient has been under observation for the past five years. In a recent check-up, we noticed a slight enlargement in the tumor's vicinity. Today, our plan is to conduct a second cryoablation procedure.
Indolent lymphoma is a slow-growing tumor, and currently, there are no highly effective drugs for its control. The primary treatment method is observation and waiting until it grows significantly, at which point chemotherapy may be considered. In this case, we are opting for an ablation, just like five years ago. This cryoablation will help control it effectively. When there are signs of growth after five years, we will perform another cryoablation to achieve excellent local control and extend the patient's life significantly.
